The week's investing action plan includes a strong dose of pharma and biotech earnings, January econ reports, plus Amazon and Alphabet.

We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says He’s In Waiting For AI GPU Spending ...

AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq ...

CNBC's Jim Cramer joins 'Halftime Report' to break down outlooks on Nvidia's tough week. Understand the pairings that will ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a ...

We recently published a list of Jim Cramer Discusses These 10 Stocks, The Fed Chair & Lower AI Costs. In this article, we are ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a ...

We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at ...

CNBC's Jim Cramer continues to like Nvidia stock despite its recent sell-off. Two other analysts also think the shares are cheap now.

In a fresh appearance on CNBC’s Squawk on the Street, Jim Cramer cautioned viewers to not be caught up by the energy that’s ...

For the Mad Money host, solid earnings results matter more now than monetary policy, as “good profits combined with a benign ...